Gray Nancy Ryan
Director at LGND
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Nov 7, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LGNDLIGAND PHARMACEUTICALS INCDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice LGNDNoticeFeb 28, 2024 2024
Filed to sell 831 shares ($75k)
Gray Nancy Ryan, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice LGNDNoticeMay 9, 2024 +71 days
Filed to sell 934 shares ($78k)
Gray Nancy Ryan, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale LGNDNo planMay 9, 2024 same day
Sold 934 shares at $83.20 ($78k)
Gray Nancy Ryan, Director
No 10b5-1 planSold 14.2% of holdings ($546k position)5,633 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale LGNDUnusualNov 7, 2025 +547 days
Sold 6,571 shares at $205.45 ($1.4M)
Gray Nancy Ryan, Director
No 10b5-1 planSold 44.8% of holdings ($3M position)8,094 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Nov 12, 2025 | LGND | Director | Form 4 sale | 6,571 | $1.4M | 44.8% | Unusual | SEC |
| May 9, 2024 | May 17, 2024 | LGND | Director | Form 4 sale | 934 | $78k | 14.2% | No plan | SEC |
| May 9, 2024 | May 9, 2024 | LGND | Director | Form 144 notice | 934 | $78k | Notice | SEC | |
| Feb 28, 2024 | Feb 28, 2024 | LGND | Director | Form 144 notice | 831 | $75k | Notice | SEC |